Tagged Articles

Solco Healthcare 4 articles

Class action lawsuit filed over tainted blood pressure meds

A second class action lawsuit was filed against manufacturers and distributors of a high blood pressure drug that was found to be contaminated with a probable cancer-causing impurity. The lawsuit was filed in Boston federal court against New Jersey-based Camber Pharmaceuticals Inc., and Hetero Drugs Ltd. Hetero is based in India but makes the drug ingredient, valsartan, with its partner, Hetero USA Inc., also based in New Jersey. The lawsuit claims poor safety procedures at the India plant should have tipped the companies off years ago that the drugs could be contaminated. Instead, the companies “willfully ignored warning signs.” In ... Read More

Class action filed against makers, distributors of contaminated BP drug

A St. Louis man filed a class action lawsuit against a number of drug companies for manufacturing and distributing certain blood pressure and heart failure medications containing the active ingredient valsartan that may have been contaminated with a probable carcinogen. James Jones filed the lawsuit in the U.S. District Court for the Eastern District of Missouri two months after the Food and Drug Administration (FDA) informed the public about the issue and announced the first wave of recalls of drugs that contained valsartan. Companies named in the lawsuit are Zhejiang Huahai Pharmaceutical Co. Ltd., Prinston Pharmaceuticals, Solco Healthcare U.S. LLC, ... Read More

More blood pressure pills recalled due to cancer-causing contaminant

The list of valsartan-containing blood pressure and heart failure drugs recalled due to the presence of a cancer-causing substance has once again expanded to include all lots of Torrent Pharmaceuticals Limited valsartan/amlodipine/HCTZ, valsartan/amlodipine, and valsartan tablets, according to the Food and Drug Administration (FDA). The recall was initiated on July 13 for certain valsartan tablets because they were found to contain a chemical known as N-nitrocodimethylamine (NDMA) in levels that exceeded those considered acceptable for public safety. The chemical is sometimes found in water supplies and food and is classified by the Environmental Protection Agency (EPA) as a probable human ... Read More

Blood pressure meds contaminated with carcinogen recalled

Several brands of the high blood pressure and heart failure drug Valsartan nd Valsartan/Hydrochlorothiazide are being recalled because the medication is contaminated with trace amounts of a known human carcinogen called N-nitrosodimethylamine (NDMA). The presence of the impurity was unexpected and is thought to be related to changes in the way the active substance was manufactured. NDMA is classified as a probable human carcinogen by the International Agency for Research on Cancer (IARC), an intergovernmental agency forming part of the World Health Organization of the United Nations. Studies have linked NDMA exposure to liver, respiratory tract, kidney and blood vessel tumors ... Read More